Dosage and administration
Adults Only: Spray twice under the tongue three times a day. This bottle contains about a 1 month supply. Some notice improvement within 2 to 3 weeks, others longer.
Adults Only: Spray twice under the tongue three times a day. This bottle contains about a 1 month supply. Some notice improvement within 2 to 3 weeks, others longer.
Human Growth Hormone 30X (2 parts), Pituitaria Glandula 30X (2 parts), Hepar Suis 6X (1 part).
For temporary relief of some of the symptoms of aging and/or a run-down condition, which may include: low energy, lack of vigor, sleeplessness.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if symptoms persist, worsen or if new symptoms occur.
If pregnant or breast-feeding, consult a health professional before use.
FOR YOUR PROTECTION, THERE IS A SEAL AROUND THE NECK OF THE BOTTLE. DO NOT USE IF SEAL IS BROKEN OR MISSING.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adults Only: Spray twice under the tongue three times a day. This bottle contains about a 1 month supply. Some notice improvement within 2 to 3 weeks, others longer.
For temporary relief of some of the symptoms of aging and/or a run-down condition, which may include: low energy, lack of vigor, sleeplessness.
Organic alcohol 20% v/v, Purified water.
:Distributed by:
OxyLife Nutritional Supplements Inc.
P.O. Box 6451
Chula Vista, CA 91909
Toll Free: 877-982-9800 www.oxylifeco.com
Made in USA with foreign and U.S. components
OxyLife
GH
HOMEOPATHIC FORMULA
Approximately 180 sprays
2 FL OZ. (60 ml)
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0697983007715 | GTIN-13: 0697983007715 EAN-13: 0697983007715 GTIN-12: 697983007715 UPC-A: 697983007715 GTIN storage (14 digits): 00697983007715 | OXYL01 GH 9-19-17.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 79c101e4-e5e3-43d7-be20-f7477d1e7556 | Product name | 1 | 20241230 |
| 34b7b043-6d89-4d95-9bed-7f5f2b49e6ef | Product name | 2 | 20200325 |
| 37e0ae3d-ccb0-0ec8-fae8-e1f0917a8a04 | Product name | 2 | 20200325 |
| 739a54c2-5f56-495a-aa67-4295fbc1cc86 | Product name | 2 | 20200325 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49295-0001-1 | GH | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 2 | |
| SOMATROPIN | ACTIVE INGREDIENT | NQX9KB6PCL | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 2 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 2 | |
| SOMATROPIN | ACTIVE MOIETY | NQX9KB6PCL | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49295-0001 | 49295-0001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SOMATROPIN | NQX9KB6PCL | ACTIB |
| SUS SCROFA PITUITARY GLAND, POSTERIOR | E8S87O660T | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GH | HUMAN GROWTH HORMONE, PITUITARIA GLANDULA, HEPAR SUIS | Oxylife Nutritional Supplements Inc | e2fb1492-1735-4f11-8784-a77e9d9ac86f | 2026-05-13 | Warnings | 49295-0001-1 49295-0001 49295000101 d767209b-d9b5-486f-b538-de1cc2fa28b8 e2fb1492-1735-4f11-8784-a77e9d9ac86f |
Adverse event summaries are temporarily unavailable. Other product information remains available.